Furanyl Fatty Acid Inhibition of FABP5 as a Mechanism for Treatment and Prevention of Cancer
Abstract
We propose that inhibition of FABP5 represents a novel approach to diverting endogenous RA from pro-proliferative (PPAR ) to anti-proliferative (RAR) receptors, and further propose the use of furan-containing fatty acids as agents to target RA to RAR. We hypothesize that this pharmacologic inhibition will prevent the oncogenic effects of FABP5 overexpression in highly relevant breast cancer models that display a high ratio of FABP5:CRABP-II expression.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1048754
Entities
People
- Gregory P Tochtrop
Organizations
- Case Western Reserve University